Clinical Trials Directory

Trials / Completed

CompletedNCT06480812

The Role of Synbiotics in Modulating Host Physiology Via the Gut Microbiome

The Role of a Synbiotic in Modulating Host Physiology Via the Gut Microbiome- A Pilot Randomised Controlled Dietary Intervention Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Elizabeth Simpson · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The current study is a proof of concept mechanistic study that will utilise a combination of prebiotic and probiotic (synbiotic) supplements. The proposed study will improve our understanding of the molecular mechanisms linking nutrition to health outcomes that are mediated by the gut microbiome.

Detailed description

The aim of this study is to generate high quality pilot data examining the role of a combination of pre and probiotic (synbiotic) supplementation in improving metabolic health (particularly systemic inflammation) and quality of life. Specific Aim 1: To deliver a wealth of data, including effect sizes, on the physiological effects of synbiotic supplementation on the changes in the microbiome and metabolomic profile of an individual. Specific Aim 2: To investigate potential mechanisms whereby the gut microbiome modulates crucial physiological parameters such as inflammatory markers and mental well-being measures.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSynbioticThe proposed protocol will provide a simple but robust intervention study using a synbiotic (pre and probiotic combination) in order to improve our understanding of the mechanisms linking nutrition to health outcomes that are mediated by the gut microbiome. This pilot study will comprise a controlled randomised intervention in which participants will be grouped into the active synbiotic arm or the control arm. The ratios will be 10g of the prebiotic supplement and 170ml of kefir. Randomisation will control for equal distribution of age and biological sex; characteristics that may confound between group comparisons and will be assessed by analysis of baseline data.

Timeline

Start date
2023-07-24
Primary completion
2024-06-12
Completion
2024-12-22
First posted
2024-06-28
Last updated
2025-05-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06480812. Inclusion in this directory is not an endorsement.